🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall aim of the trial is to evaluate the safety, tolerability, and p...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2020-03-04
Trial ID
NCT04221542
Treatments Being Tested
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
Multicentre, 2 arm, open-label UK randomised phase II trial to determine th...
Status
Completed
Location
University Hospital Southampton, Southampton General Hospital
Start Date
2022-07-11
Trial ID
NCT05455424
Treatments Being Tested
The purpose of this study is to see whether a supportive intervention (REVI...
Status
Recruiting
Location
University of Colorado Cancer Center-Anschutz
Start Date
2025-03-17
Trial ID
NCT06710548
Treatments Being Tested
A phase II study combining pembrolizumab with olaparib in metastatic pancre...
Status
Recruiting
Location
Monash Health
Start Date
2025-02-26
Trial ID
NCT05093231
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested
In tumors with a defect in the homologous recombination (HR) pathway, doubl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-11
Trial ID
NCT03044795
Treatments Being Tested
This a prospective real-world navigation study using tumor DNA sequencing t...
Status
Active Not Recruiting
Location
Peking University Cancer Hospital
Start Date
2020-09-23
Trial ID
NCT04584008
Breast cancer is the most common malignancy in women; approximately 5-10% a...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-01-20
Trial ID
NCT07321015
Treatments Being Tested